Click for best price
Membranous Nephropathy Market Size, Share 2024
The global Membranous Nephropathy market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Alkylating Agents Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Membranous Nephropathy include Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries Ltd, Bristol Myers Squibb Company and FibroGen, Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Membranous nephropathy is also known as silent kidney problem and is considered as a form of glomerular disease. It is occurred when the glomeruli became damage and thickened that causes edema and heavy proteinuria. As a result, it leads to reduced kidney function and swelling. Membranous nephropathy can be caused by numerous factors such as autoimmune disease, use of certain medications such as nonsteroidal anti-inflammatory drugs, and exposure to certain infections such as hepatitis B, hepatitis C, and syphilis.
This report aims to provide a comprehensive presentation of the global market for Membranous Nephropathy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Membranous Nephropathy. This report contains market size and forecasts of Membranous Nephropathy in global, including the following market information:
Global Membranous Nephropathy Market Revenue, 2020-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Membranous Nephropathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Membranous Nephropathy Market, by Type, 2020-2024, 2025-2030 ($ millions)
Global Membranous Nephropathy Market Segment Percentages, by Type, 2023 (%)
Alkylating Agents
Cyclophosphamide
Chlorambucil
Tacrolimus
MycophenolateMofetil
Other
Global Membranous Nephropathy Market, by Application, 2020-2024, 2025-2030 ($ millions)
Global Membranous Nephropathy Market Segment Percentages, by Application, 2023 (%)
Hospial
Specialty Clinic
Other
Global Membranous Nephropathy Market, By Region and Country, 2020-2024, 2025-2030 ($ Millions)
Global Membranous Nephropathy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Membranous Nephropathy revenues in global market, 2020-2024 (estimated), ($ millions)
Key companies Membranous Nephropathy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
F. Hoffmann-La Roche Ltd
Mylan N.V
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
Novartis AG
Teva Pharmaceutical Industries Ltd
Bristol Myers Squibb Company
FibroGen, Inc
Mayne Pharma Group Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Membranous Nephropathy, market overview.
Chapter 2: Global Membranous Nephropathy market size in revenue.
Chapter 3: Detailed analysis of Membranous Nephropathy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Membranous Nephropathy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Membranous Nephropathy Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Membranous Nephropathy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Membranous Nephropathy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Membranous Nephropathy Overall Market Size
2.1 Global Membranous Nephropathy Market Size: 2023 VS 2030
2.2 Global Membranous Nephropathy Market Size, Prospects & Forecasts: 2020-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Membranous Nephropathy Players in Global Market
3.2 Top Global Membranous Nephropathy Companies Ranked by Revenue
3.3 Global Membranous Nephropathy Revenue by Companies
3.4 Top 3 and Top 5 Membranous Nephropathy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Membranous Nephropathy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Membranous Nephropathy Players in Global Market
3.6.1 List of Global Tier 1 Membranous Nephropathy Companies
3.6.2 List of Global Tier 2 and Tier 3 Membranous Nephropathy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Membranous Nephropathy Market Size Markets, 2023 & 2030
4.1.2 Alkylating Agents
4.1.3 Cyclophosphamide
4.1.4 Chlorambucil
4.1.5 Tacrolimus
4.1.6 MycophenolateMofetil
4.1.7 Other
4.2 By Type - Global Membranous Nephropathy Revenue & Forecasts
4.2.1 By Type - Global Membranous Nephropathy Revenue, 2020-2024
4.2.2 By Type - Global Membranous Nephropathy Revenue, 2025-2030
4.2.3 By Type - Global Membranous Nephropathy Revenue Market Share, 2020-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Membranous Nephropathy Market Size, 2023 & 2030
5.1.2 Hospial
5.1.3 Specialty Clinic
5.1.4 Other
5.2 By Application - Global Membranous Nephropathy Revenue & Forecasts
5.2.1 By Application - Global Membranous Nephropathy Revenue, 2020-2024
5.2.2 By Application - Global Membranous Nephropathy Revenue, 2025-2030
5.2.3 By Application - Global Membranous Nephropathy Revenue Market Share, 2020-2030
6 Sights by Region
6.1 By Region - Global Membranous Nephropathy Market Size, 2023 & 2030
6.2 By Region - Global Membranous Nephropathy Revenue & Forecasts
6.2.1 By Region - Global Membranous Nephropathy Revenue, 2020-2024
6.2.2 By Region - Global Membranous Nephropathy Revenue, 2025-2030
6.2.3 By Region - Global Membranous Nephropathy Revenue Market Share, 2020-2030
6.3 North America
6.3.1 By Country - North America Membranous Nephropathy Revenue, 2020-2030
6.3.2 US Membranous Nephropathy Market Size, 2020-2030
6.3.3 Canada Membranous Nephropathy Market Size, 2020-2030
6.3.4 Mexico Membranous Nephropathy Market Size, 2020-2030
6.4 Europe
6.4.1 By Country - Europe Membranous Nephropathy Revenue, 2020-2030
6.4.2 Germany Membranous Nephropathy Market Size, 2020-2030
6.4.3 France Membranous Nephropathy Market Size, 2020-2030
6.4.4 U.K. Membranous Nephropathy Market Size, 2020-2030
6.4.5 Italy Membranous Nephropathy Market Size, 2020-2030
6.4.6 Russia Membranous Nephropathy Market Size, 2020-2030
6.4.7 Nordic Countries Membranous Nephropathy Market Size, 2020-2030
6.4.8 Benelux Membranous Nephropathy Market Size, 2020-2030
6.5 Asia
6.5.1 By Region - Asia Membranous Nephropathy Revenue, 2020-2030
6.5.2 China Membranous Nephropathy Market Size, 2020-2030
6.5.3 Japan Membranous Nephropathy Market Size, 2020-2030
6.5.4 South Korea Membranous Nephropathy Market Size, 2020-2030
6.5.5 Southeast Asia Membranous Nephropathy Market Size, 2020-2030
6.5.6 India Membranous Nephropathy Market Size, 2020-2030
6.6 South America
6.6.1 By Country - South America Membranous Nephropathy Revenue, 2020-2030
6.6.2 Brazil Membranous Nephropathy Market Size, 2020-2030
6.6.3 Argentina Membranous Nephropathy Market Size, 2020-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Membranous Nephropathy Revenue, 2020-2030
6.7.2 Turkey Membranous Nephropathy Market Size, 2020-2030
6.7.3 Israel Membranous Nephropathy Market Size, 2020-2030
6.7.4 Saudi Arabia Membranous Nephropathy Market Size, 2020-2030
6.7.5 UAE Membranous Nephropathy Market Size, 2020-2030
7 Membranous Nephropathy Companies Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Membranous Nephropathy Major Product Offerings
7.1.4 Pfizer Inc Membranous Nephropathy Revenue in Global Market (2020-2024)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Company Summary
7.2.2 F. Hoffmann-La Roche Ltd Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Membranous Nephropathy Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd Membranous Nephropathy Revenue in Global Market (2020-2024)
7.2.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.3 Mylan N.V
7.3.1 Mylan N.V Company Summary
7.3.2 Mylan N.V Business Overview
7.3.3 Mylan N.V Membranous Nephropathy Major Product Offerings
7.3.4 Mylan N.V Membranous Nephropathy Revenue in Global Market (2020-2024)
7.3.5 Mylan N.V Key News & Latest Developments
7.4 Fresenius Kabi AG
7.4.1 Fresenius Kabi AG Company Summary
7.4.2 Fresenius Kabi AG Business Overview
7.4.3 Fresenius Kabi AG Membranous Nephropathy Major Product Offerings
7.4.4 Fresenius Kabi AG Membranous Nephropathy Revenue in Global Market (2020-2024)
7.4.5 Fresenius Kabi AG Key News & Latest Developments
7.5 Hikma Pharmaceuticals PLC
7.5.1 Hikma Pharmaceuticals PLC Company Summary
7.5.2 Hikma Pharmaceuticals PLC Business Overview
7.5.3 Hikma Pharmaceuticals PLC Membranous Nephropathy Major Product Offerings
7.5.4 Hikma Pharmaceuticals PLC Membranous Nephropathy Revenue in Global Market (2020-2024)
7.5.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Membranous Nephropathy Major Product Offerings
7.6.4 Novartis AG Membranous Nephropathy Revenue in Global Market (2020-2024)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Membranous Nephropathy Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd Membranous Nephropathy Revenue in Global Market (2020-2024)
7.7.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Bristol Myers Squibb Company
7.8.1 Bristol Myers Squibb Company Company Summary
7.8.2 Bristol Myers Squibb Company Business Overview
7.8.3 Bristol Myers Squibb Company Membranous Nephropathy Major Product Offerings
7.8.4 Bristol Myers Squibb Company Membranous Nephropathy Revenue in Global Market (2020-2024)
7.8.5 Bristol Myers Squibb Company Key News & Latest Developments
7.9 FibroGen, Inc
7.9.1 FibroGen, Inc Company Summary
7.9.2 FibroGen, Inc Business Overview
7.9.3 FibroGen, Inc Membranous Nephropathy Major Product Offerings
7.9.4 FibroGen, Inc Membranous Nephropathy Revenue in Global Market (2020-2024)
7.9.5 FibroGen, Inc Key News & Latest Developments
7.10 Mayne Pharma Group Limited
7.10.1 Mayne Pharma Group Limited Company Summary
7.10.2 Mayne Pharma Group Limited Business Overview
7.10.3 Mayne Pharma Group Limited Membranous Nephropathy Major Product Offerings
7.10.4 Mayne Pharma Group Limited Membranous Nephropathy Revenue in Global Market (2020-2024)
7.10.5 Mayne Pharma Group Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Membranous Nephropathy Market Opportunities & Trends in Global Market
Table 2. Membranous Nephropathy Market Drivers in Global Market
Table 3. Membranous Nephropathy Market Restraints in Global Market
Table 4. Key Players of Membranous Nephropathy in Global Market
Table 5. Top Membranous Nephropathy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Membranous Nephropathy Revenue by Companies, (US$, Mn), 2020-2024
Table 7. Global Membranous Nephropathy Revenue Share by Companies, 2020-2024
Table 8. Global Companies Membranous Nephropathy Product Type
Table 9. List of Global Tier 1 Membranous Nephropathy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Membranous Nephropathy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Membranous Nephropathy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Membranous Nephropathy Revenue in Global (US$, Mn), 2020-2024
Table 13. By Type - Membranous Nephropathy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Membranous Nephropathy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Membranous Nephropathy Revenue in Global (US$, Mn), 2020-2024
Table 16. By Application - Membranous Nephropathy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Membranous Nephropathy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Membranous Nephropathy Revenue (US$, Mn), 2020-2024
Table 19. By Region - Global Membranous Nephropathy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Membranous Nephropathy Revenue, (US$, Mn), 2020-2024
Table 21. By Country - North America Membranous Nephropathy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Membranous Nephropathy Revenue, (US$, Mn), 2020-2024
Table 23. By Country - Europe Membranous Nephropathy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Membranous Nephropathy Revenue, (US$, Mn), 2020-2024
Table 25. By Region - Asia Membranous Nephropathy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Membranous Nephropathy Revenue, (US$, Mn), 2020-2024
Table 27. By Country - South America Membranous Nephropathy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Membranous Nephropathy Revenue, (US$, Mn), 2020-2024
Table 29. By Country - Middle East & Africa Membranous Nephropathy Revenue, (US$, Mn), 2025-2030
Table 30. Pfizer Inc Company Summary
Table 31. Pfizer Inc Membranous Nephropathy Product Offerings
Table 32. Pfizer Inc Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 33. Pfizer Inc Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Ltd Company Summary
Table 35. F. Hoffmann-La Roche Ltd Membranous Nephropathy Product Offerings
Table 36. F. Hoffmann-La Roche Ltd Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 37. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 38. Mylan N.V Company Summary
Table 39. Mylan N.V Membranous Nephropathy Product Offerings
Table 40. Mylan N.V Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 41. Mylan N.V Key News & Latest Developments
Table 42. Fresenius Kabi AG Company Summary
Table 43. Fresenius Kabi AG Membranous Nephropathy Product Offerings
Table 44. Fresenius Kabi AG Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 45. Fresenius Kabi AG Key News & Latest Developments
Table 46. Hikma Pharmaceuticals PLC Company Summary
Table 47. Hikma Pharmaceuticals PLC Membranous Nephropathy Product Offerings
Table 48. Hikma Pharmaceuticals PLC Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 49. Hikma Pharmaceuticals PLC Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Membranous Nephropathy Product Offerings
Table 52. Novartis AG Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 53. Novartis AG Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Summary
Table 55. Teva Pharmaceutical Industries Ltd Membranous Nephropathy Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 57. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Bristol Myers Squibb Company Company Summary
Table 59. Bristol Myers Squibb Company Membranous Nephropathy Product Offerings
Table 60. Bristol Myers Squibb Company Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 61. Bristol Myers Squibb Company Key News & Latest Developments
Table 62. FibroGen, Inc Company Summary
Table 63. FibroGen, Inc Membranous Nephropathy Product Offerings
Table 64. FibroGen, Inc Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 65. FibroGen, Inc Key News & Latest Developments
Table 66. Mayne Pharma Group Limited Company Summary
Table 67. Mayne Pharma Group Limited Membranous Nephropathy Product Offerings
Table 68. Mayne Pharma Group Limited Membranous Nephropathy Revenue (US$, Mn) & (2020-2024)
Table 69. Mayne Pharma Group Limited Key News & Latest Developments
List of Figures
Figure 1. Membranous Nephropathy Segment by Type in 2023
Figure 2. Membranous Nephropathy Segment by Application in 2023
Figure 3. Global Membranous Nephropathy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Membranous Nephropathy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Membranous Nephropathy Revenue, 2020-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Membranous Nephropathy Revenue in 2023
Figure 8. By Type - Global Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 9. By Application - Global Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 10. By Type - Global Membranous Nephropathy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 12. By Application - Global Membranous Nephropathy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 14. By Region - Global Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 15. By Country - North America Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 16. US Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 17. Canada Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 18. Mexico Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 19. By Country - Europe Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 20. Germany Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 21. France Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 22. U.K. Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 23. Italy Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 24. Russia Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 25. Nordic Countries Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 26. Benelux Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 27. By Region - Asia Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 28. China Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 29. Japan Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 30. South Korea Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 31. Southeast Asia Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 32. India Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 33. By Country - South America Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 34. Brazil Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 35. Argentina Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 36. By Country - Middle East & Africa Membranous Nephropathy Revenue Market Share, 2020-2030
Figure 37. Turkey Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 38. Israel Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 39. Saudi Arabia Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 40. UAE Membranous Nephropathy Revenue, (US$, Mn), 2020-2030
Figure 41. Pfizer Inc Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 42. F. Hoffmann-La Roche Ltd Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 43. Mylan N.V Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 44. Fresenius Kabi AG Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 45. Hikma Pharmaceuticals PLC Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 46. Novartis AG Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 47. Teva Pharmaceutical Industries Ltd Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 48. Bristol Myers Squibb Company Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 49. FibroGen, Inc Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 50. Mayne Pharma Group Limited Membranous Nephropathy Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
